Abiraterone

Product NDC
0143-9597
11-digit product format
001439597
Labeler code
0143
Product ID
0143-9597_35e5846f-9299-4190-94bb-6b0bb0d92485
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Abiraterone acetate
Dosage form
TABLET
Route
ORAL
Labeler
Hikma Pharmaceuticals USA Inc.
Application
ANDA208339
Marketing category
ANDA
Marketing start
2018-11-23
Substance
ABIRATERONE ACETATE
Active strength
250 mg/1
Pharmacologic classes
Cytochrome P450 17A1 Inhibitor [EPC], Cytochrome P450 17A1 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A208339-001ABIRATERONE ACETATEABIRATERONE ACETATE250MGTABLET / ORALAB2018-10-31

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
A208339-001AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-08-01 22:54:322026-06A208339-001ABIRATERONE ACETATE250MGTABLET / ORALAB2018-10-31a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-08-01 22:54:322026-06A208339-001AB1a50c72e98297…

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 4 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
AbirateroneABIRATERONE ACETATECivicaScript, LLC0ef857ee-2bfc-4d27-a417-ad58fc3a6ff62025-10-21Warnings, Adverse reactionsExact identifier
application applno (ANDA): 208339
application number: ANDA208339
AbirateroneABIRATERONE ACETATEPD-Rx Pharmaceuticals, Inc.413c645e-074d-4276-b39a-d835210776022025-10-08Warnings, Adverse reactionsExact identifier
application applno (ANDA): 208339
application number: ANDA208339
AbirtegaABIRATERONE ACETATECivicaScript, LLC2f932015-28b2-4f44-ac04-772e982e13e92025-02-28Warnings, Adverse reactionsExact identifier
application applno (ANDA): 208339
application number: ANDA208339
AbirateroneABIRATERONE ACETATEHikma Pharmaceuticals USA Inc.be29365a-ed25-44c0-9818-e9016dc95ba62024-12-20Warnings, Adverse reactionsExact identifier
application applno (ANDA): 208339
application number: ANDA208339
ndc (product): 0143-9597

Additional Listing Data#

Finished product
Yes
Brand name base
Abiraterone
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
ABIRATERONE ACETATE250 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
EM5OCB9YJ6Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
1100075Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
be29365a-ed25-44c0-9818-e9016dc95ba6Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
e8e8aba9-b811-8b6a-ff1e-1aec10655d95Product name820240223
8f213b7a-23f6-497c-a54d-8a37f1798781Product name120231023
fb7d5d26-0d70-42a5-a005-42898b3cfc3fProduct name120180730

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
0143-9597-21Abiraterone120 in 1 BOTTLETABLET12016

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0143-9597-21EA - Each0143-9597167ebf82-8fa2-4e23-b011-30a9d603c88412018-12-13

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
0143-9597ABIRATERONE (ABIRATERONE ACETATE) TABLET [HIKMA PHARMACEUTICALS USA INC.]16Current NDC, Legacy NDC, 1 package rows20250430_be29365a-ed25-44c0-9818-e9016dc95ba6.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
1100075abiraterone acetate 250 MG Oral TabletPSN413c645e-074d-4276-b39a-d8352107760216
1100075abiraterone acetate 250 MG Oral TabletPSNbe29365a-ed25-44c0-9818-e9016dc95ba616
1100075abiraterone acetate 250 MG Oral TabletSCD413c645e-074d-4276-b39a-d8352107760216
1100075abiraterone acetate 250 MG Oral TabletSCDbe29365a-ed25-44c0-9818-e9016dc95ba616

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
0143-9597-2100143959721120 TABLET in 1 BOTTLE (0143-9597-21) 120 tablet2018-11-230000-00-00NoNoCurrent